Discovery of GS-7682, a Novel 4′-Cyano-Modified C -Nucleoside Prodrug with Broad Activity against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green Monkeys
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Dustin S Siegel und 39 weiteren Autor:innen. Beteiligte Einrichtung: Gilead Sciences, Inc., Foster City, California 94404, United States. Hauptthemen laut MEDLINE: Antiviral Agents, Prodrugs, Respiratory Syncytial Virus Infections, Picornaviridae. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Acute respiratory viral infections, such as pneumovirus and respiratory picornavirus infections, exacerbate disease in COPD and asthma patients. A research program targeting respiratory syncytial virus (RSV) led to the discovery of GS-7682 (1), a novel phosphoramidate prodrug of a 4'-CN-4-aza-7,9-dideazaadenosine C-nucleoside GS-646089 (2) with broad antiviral activity against RSV (EC50 = 3-46 nM), human metapneumovirus (EC50 = 210 nM), human rhinovirus (EC50 = 54-61 nM), and enterovirus (EC50 = 83-90 nM). Prodrug optimization for cellular potency and lung cell metabolism identified 5'-methyl [(S)-hydroxy(phenoxy)phosphoryl]-l-alaninate in combination with 2',3'-diisobutyrate promoieties as being optimal for high levels of intracellular triphosphate formation in vitro and in vivo. 1 demonstrated significant reductions of viral loads in the lower respiratory tract of RSV-infected African green monkeys when administered once daily via intratracheal nebulized aerosol. Together, these findings support additional evaluation of 1 and its analogues as potential therapeutics for pneumo- and picornaviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gilead Sciences, Inc., Foster City, California 94404, United States.
- Lovelace Biomedical, Albuquerque, New Mexico 87108, United States.
- Inspired - Pulmonary Solutions, San Carlos, California 94070, United States.
ORCID-Profile: Dustin S Siegel, Jason K Perry, Philip J Kuehl, Richard L Mackman
Zitieren
APA
Siegel, D. S., Hui, H. C., Pitts, J., Vermillion, M. S., Ishida, K., Rautiola, D., Keeney, M., Irshad, H., Zhang, L., Chun, K., Chin, G., Goyal, B., Doerffler, E., Yang, H., Clarke, M. O., Palmiotti, C., Vijjapurapu, A., Riola, N. C., Stray, K., …, & Mackman, R. L. (2024). Discovery of GS-7682, a Novel 4′-Cyano-Modified C -Nucleoside Prodrug with Broad Activity against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green Monkeys. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00899
Vancouver
Siegel DS, Hui HC, Pitts J, Vermillion MS, Ishida K, Rautiola D, et al. Discovery of GS-7682, a Novel 4′-Cyano-Modified C -Nucleoside Prodrug with Broad Activity against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green Monkeys. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00899
BibTeX
@article{Siegel2024,
author = {Siegel, Dustin S and Hui, Hon C and Pitts, Jared and Vermillion, Meghan S and Ishida, Kazuya and Rautiola, Davin and Keeney, Michael and Irshad, Hammad and Zhang, Lijun and Chun, Kwon and Chin, Gregory and Goyal, Bindu and Doerffler, Edward and Yang, Hai and Clarke, Michael O and Palmiotti, Chris and Vijjapurapu, Arya and Riola, Nicholas C and Stray, Kirsten and Murakami, Eisuke and Ma, Bin and Wang, Ting and Zhao, Xiaofeng and Xu, Yili and Lee, Gary and Marchand, Bruno and Seung, Minji and Nayak, Arabinda and Tomkinson, Adrian and Kadrichu, Nani and Ellis, Scott and Barauskas, Ona and Feng, Joy Y and Perry, Jason K and Perron, Michel and Bilello, John P and Kuehl, Philip J and Subramanian, Raju and Cihlar, Tomas and Mackman, Richard L},
title = {Discovery of GS-7682, a Novel 4′-Cyano-Modified C -Nucleoside Prodrug with Broad Activity against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green Monkeys},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00899}
}
EUVIMED